日本ケミファの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/11/21 | 1,500 | 1,514 | 1,500 | 1,514 | +13 | +0.9% | 1,400 |
| 2024/11/20 | 1,509 | 1,509 | 1,500 | 1,501 | -8 | -0.5% | 500 |
| 2024/11/19 | 1,500 | 1,522 | 1,500 | 1,509 | +9 | +0.6% | 4,900 |
| 2024/11/18 | 1,485 | 1,507 | 1,485 | 1,500 | +15 | +1% | 2,500 |
| 2024/11/15 | 1,485 | 1,506 | 1,485 | 1,485 | ±0 | ±0% | 800 |
| 2024/11/14 | 1,494 | 1,494 | 1,485 | 1,485 | -15 | -1% | 2,900 |
| 2024/11/13 | 1,500 | 1,500 | 1,500 | 1,500 | +3 | +0.2% | 400 |
| 2024/11/12 | 1,490 | 1,497 | 1,490 | 1,497 | +6 | +0.4% | 600 |
| 2024/11/11 | 1,490 | 1,505 | 1,490 | 1,491 | +1 | +0.1% | 1,700 |
| 2024/11/08 | 1,491 | 1,492 | 1,490 | 1,490 | -10 | -0.7% | 10,300 |
| 2024/11/07 | 1,500 | 1,522 | 1,500 | 1,500 | ±0 | ±0% | 1,400 |
| 2024/11/06 | 1,508 | 1,508 | 1,500 | 1,500 | -4 | -0.3% | 900 |
| 2024/11/05 | 1,505 | 1,510 | 1,504 | 1,504 | +3 | +0.2% | 800 |
| 2024/11/01 | 1,496 | 1,519 | 1,496 | 1,501 | -30 | -2% | 6,800 |
| 2024/10/31 | 1,485 | 1,531 | 1,485 | 1,531 | +55 | +3.7% | 7,200 |
| 2024/10/30 | 1,532 | 1,542 | 1,476 | 1,476 | -67 | -4.3% | 28,500 |
| 2024/10/29 | 1,545 | 1,550 | 1,540 | 1,543 | -5 | -0.3% | 2,000 |
| 2024/10/28 | 1,532 | 1,548 | 1,532 | 1,548 | +15 | +1% | 3,000 |
| 2024/10/25 | 1,553 | 1,556 | 1,533 | 1,533 | -37 | -2.4% | 4,700 |
| 2024/10/24 | 1,575 | 1,575 | 1,550 | 1,570 | -5 | -0.3% | 2,600 |
| 2024/10/23 | 1,588 | 1,588 | 1,575 | 1,575 | -14 | -0.9% | 1,900 |
| 2024/10/22 | 1,589 | 1,589 | 1,589 | 1,589 | -1 | -0.1% | 300 |
| 2024/10/21 | 1,590 | 1,590 | 1,579 | 1,590 | ±0 | ±0% | 1,300 |
| 2024/10/18 | 1,592 | 1,613 | 1,590 | 1,590 | -1 | -0.1% | 3,300 |
| 2024/10/17 | 1,625 | 1,625 | 1,591 | 1,591 | -2 | -0.1% | 300 |
| 2024/10/16 | 1,602 | 1,612 | 1,593 | 1,593 | -9 | -0.6% | 1,300 |
| 2024/10/15 | 1,602 | 1,605 | 1,600 | 1,602 | +1 | +0.1% | 800 |
| 2024/10/11 | 1,601 | 1,601 | 1,601 | 1,601 | -5 | -0.3% | 100 |
| 2024/10/10 | 1,633 | 1,633 | 1,606 | 1,606 | - | - | 300 |
| 2024/10/09 | 0 | 0 | 0 | 0 | - | - | 0 |
| 2024/10/08 | 1,618 | 1,627 | 1,615 | 1,627 | +13 | +0.8% | 1,200 |
| 2024/10/07 | 1,628 | 1,650 | 1,614 | 1,614 | +5 | +0.3% | 8,900 |
| 2024/10/04 | 1,616 | 1,616 | 1,609 | 1,609 | -7 | -0.4% | 200 |
| 2024/10/03 | 1,616 | 1,616 | 1,616 | 1,616 | ±0 | ±0% | 100 |
| 2024/10/02 | 1,625 | 1,635 | 1,615 | 1,616 | -9 | -0.6% | 7,500 |
| 2024/10/01 | 1,619 | 1,634 | 1,609 | 1,625 | +46 | +2.9% | 2,500 |
| 2024/09/30 | 1,594 | 1,594 | 1,577 | 1,579 | -31 | -1.9% | 2,800 |
| 2024/09/27 | 1,629 | 1,637 | 1,610 | 1,610 | -10 | -0.6% | 1,300 |
| 2024/09/26 | 1,637 | 1,638 | 1,612 | 1,620 | -10 | -0.6% | 4,500 |
| 2024/09/25 | 1,633 | 1,643 | 1,613 | 1,630 | +2 | +0.1% | 2,700 |
| 2024/09/24 | 1,597 | 1,628 | 1,590 | 1,628 | +45 | +2.8% | 6,900 |
| 2024/09/20 | 1,588 | 1,589 | 1,574 | 1,583 | +1 | +0.1% | 900 |
| 2024/09/19 | 1,575 | 1,582 | 1,571 | 1,582 | +15 | +1% | 400 |
| 2024/09/18 | 1,580 | 1,580 | 1,565 | 1,567 | -25 | -1.6% | 10,000 |
| 2024/09/17 | 1,580 | 1,592 | 1,580 | 1,592 | +20 | +1.3% | 500 |
| 2024/09/13 | 1,582 | 1,594 | 1,572 | 1,572 | -26 | -1.6% | 2,700 |
| 2024/09/12 | 1,599 | 1,629 | 1,573 | 1,598 | +29 | +1.8% | 2,700 |
| 2024/09/11 | 1,602 | 1,602 | 1,560 | 1,569 | -35 | -2.2% | 3,700 |
| 2024/09/10 | 1,603 | 1,604 | 1,601 | 1,604 | -9 | -0.6% | 600 |
| 2024/09/09 | 1,616 | 1,616 | 1,601 | 1,613 | -12 | -0.7% | 2,100 |
1～
50
件表示中 / 3585件
類似銘柄と比較する
現在ご覧いただいている「日ケミファ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 日ケミファ | 151,400円 | +2.5% | - | 3.30% | 91.04倍 | 0.29倍 |
|
中堅後発薬メーカー。長期収載品の主力は痛風薬ウラリット。新薬開発、検査薬事業を中期強化 |
| ＯＴＳ | 3,000円 | +63.9% | - | 0.00% | - | 8.80倍 |
|
がん治療ワクチン創薬ベンチャー。大手製薬と開発提携。東大医科研発。会社計画は非開示 |
| ノイルイミューン | 16,800円 | -97.8% | - | 0.00% | - | 1.46倍 |
|
独自技術用いたＣＡＲ－Ｔ細胞免疫療法で抗がん剤を複数開発中。中外製薬とライセンス契約 |
| カルナバイオ | 31,100円 | -43.1% | - | 0.00% | - | 1.85倍 |
|
キナーゼタンパク質の販売や受託試験など創薬初期の支援事業が柱。キナーゼ阻害剤で創薬も |
| ＶＩＳ | 90,500円 | +87.8% | +265.7% | 0.00% | 54.35倍 | 2.49倍 |
|
ｍＲＮＡ標的低分子創薬技術を製薬会社に提供。共同創薬研究などによる契約金収入が柱 |
市場注目の銘柄
チャート関連のコラム
